Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
Journal of Proteome Research|February 15, 2008
Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptorJiefei Tong, Paul Taylor, Eleonora Jovceva, et al.
Leukemia & Lymphoma|January 29, 2021
A phase-1 trial of linsitinib (OSI-906) in combination with bortezomib and dexamethasone for the treatment of relapsed/refractory multiple myelomaSahar Khan, Richard LeBlanc, Martin Gyger, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 5, 2018
Single-center Experience in Treating Patients With t(4;14) Multiple Myeloma With and Without Planned Frontline Autologous Stem Cell TransplantationHenry Chan, Madeline Phillips, Manjula Maganti, et al.
Blood|July 20, 2006
MIP-1alpha (CCL3) is a downstream target of FGFR3 and RAS-MAPK signaling in multiple myelomaEsther Masih-Khan, Suzanne Trudel, Carla Heise, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 14, 2021
Fixed duration <i>vs.</i> prolonged duration treatment after first line therapy in patients with systemic light chain amyloidosisAlfonso Rivera Duarte, Donna Reece, Xuan Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2012
A phase I single-agent study of twice-weekly consecutive-day dosing of the proteasome inhibitor carfilzomib in patients with relapsed or refractory multiple myeloma or lymphomaMelissa Alsina, Suzanne Trudel, Richard R Furman, et al.
British Journal of Haematology|April 19, 2013
D(T)PACE as salvage therapy for aggressive or refractory multiple myelomaAlina S Gerrie, Joseph R Mikhael, Lu Cheng, et al.
Bone Marrow Transplantation|September 28, 2019
Toxicity and survival outcomes of autologous stem cell transplant in multiple myeloma patients with renal insufficiency: an institutional comparison between two erasAmanda Yan Li, Eshetu G Atenafu, Rosanne St Bernard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2021
A Personalized Mass Spectrometry-Based Assay to Monitor M-Protein in Patients with Multiple Myeloma (EasyM)Mariya Liyasova, Zac McDonald, Paul Taylor, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 11, 2009
Multiple myeloma phosphotyrosine proteomic profile associated with FGFR3 expression, ligand activation, and drug inhibitionJonathan R St-Germain, Paul Taylor, Jiefei Tong, et al.
Pageof 11